FGF9 and Glucose intolerance: In contrast to the results obtained in AAV-shFGF9-infected DIO mice, Ad-FGF9 injection improves glucose intolerance as revealed by GTT experiments (Figure 5B), and enhanced insulin sensitivity, as revealed by ITT experiments (Figure 5C), and enhanced hepatic insulin signaling (Figure 5D).